• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Kjel A. Johnson II, BS

Latest:

Provider and Patient Insights Into the Cancer Care Journey

A survey was conducted to determine opportunities to aid primary care providers and patients in the difficult journey of an oncology patient.


Charles Coffey Jr, MD, MS

Latest:

Choosing Wisely Interventions to Reduce Antibiotic Overuse in the Safety Net

This study evaluates the impact of Choosing Wisely–based interventions on antibiotic prescribing for viral respiratory tract infections in a real-world safety-net setting.


Nicholas Scaletta, MD

Latest:

Patient Experience in a COVID-19 Patient Home Monitoring Program

Patients who participated in a COVID-19 patient home monitoring program were satisfied with their care and stated that their participation made them less likely to seek care in the emergency department.


Shahjehan Ahmad, MD, MPH

Latest:

Implementation of Early Follow-up Care After Heart Failure Hospitalization

An early heart failure follow-up intervention succeeded in increasing referral to and completion of cardiology appointments within 7 days of discharge. The intervention was associated with lower risk of 30-day all-cause emergency department visits, all-cause hospitalizations, or death.


Juliette Cubanski, PhD

Latest:

Trends in Medicare Part D Coverage of Generics With Equivalent Brand-Name Drugs

High-tier generic drug placement in Medicare Part D has increased over time, but it may be related to a drug’s clinical profile and availability of substitutes rather than preferred brand-name drug coverage.


Stephen Murphy, PhD

Latest:

Projected US Savings From Biosimilars, 2021-2025

Projected savings from biosimilars from 2021 to 2025 were $38.4 billion vs conditions as of quarter 4 of 2020 and were driven by new biosimilar entry. Savings were $124.5 billion under an upper-bound scenario.


Leah Tuzzio, MPH

Latest:

A Value Proposition for Pragmatic Clinical Trials

The authors examine the origin, benefits, and challenges of pragmatic clinical trials to assess the ultimate value of this research design.


Daniel F. Heitjan, PhD

Latest:

Predicting Hospital Readmission in Medicaid Patients With Diabetes Using Administrative and Claims Data

A statistical model based entirely on claims data can accurately predict 30-day hospital readmission in Medicaid patients with diabetes.


Mathilde Faller, MA

Latest:

US Cost-effectiveness and Budget Impact of Point-of-Care NAAT for Streptococcus

This study evaluates the cost-effectiveness and budget impact to US payers of point-of-care nucleic acid amplification tests (NAAT) for group A streptococcus.


Wanzhen Gao, PhD, MD, MPH

Latest:

Predicting Opioid Use Disorder and Associated Risk Factors in a Medicaid Managed Care Population

A Medicaid managed care organization developed a machine learning model to identify opioid use disorder (OUD) risk factors and predict OUD incidence in its multistate population.


Rebecca Trotzky-Sirr, MD

Latest:

Choosing Wisely Interventions to Reduce Antibiotic Overuse in the Safety Net

This study evaluates the impact of Choosing Wisely–based interventions on antibiotic prescribing for viral respiratory tract infections in a real-world safety-net setting.


Carrie Jardine

Latest:

Optimizing the Management of TRD

Drs Steven Levine, Patricia Ares-Romero, Samuel Nordberg, Martin Rosenzweig, and Carrie Jardine share insight on the future treatment landscape for TRD.



Eugene B. Cone, MD

Latest:

Are Work Relative Value Units Correlated With Operative Duration of Common Surgical Procedures?

Work relative value units (wRVUs) correlate with operative duration of common surgical procedures. Reimbursement for physicians depending on wRVUs is fair for commonly performed surgeries.


Jason H. Wasfy, MD

Latest:

The Essential Role of Population Health During and Beyond COVID-19

The authors detail how population health management enables health systems to promote public health, strengthen health system resiliency, and support financial recovery during and beyond coronavirus disease 2019 (COVID-19).


E. Camille Vaughan, MD, MS

Latest:

Impact of Electronic Information Exchange on Repeat Imaging During 30-Day Readmissions Among Medicare Beneficiaries

This analysis of Medicare data examines the relationships between fragmented readmission, health information exchange, and repeat imaging in older adults with and without Alzheimer disease.


Julia Bonavitacola
Julia Bonavitacola

Latest:

Commercial FIT Capable of Similar Diagnostic Results as New Stool DNA Test

Lowering the positivity threshold for a high-quality fecal immunochemical test (FIT) can increase sensitivity of noninvasive screening for colorectal cancer in a more economical way.


Beth Creekmur, MA

Latest:

Development and Validation of the COVID-19 Hospitalized Patient Deterioration Index

The authors developed and validated an accurate, well-calibrated, easy-to-implement COVID-19 hospitalized patient deterioration index to identify patients at high or low risk of clinical deterioration.


Lisa Balentine, BASc

Latest:

Tacking Upwind: Reducing Spending Among High-risk Commercially Insured Patients

Although commercial accountable care organization populations are healthy on average, some individuals might benefit from programs for high-risk patients to mitigate high levels of health care utilization.


Alexandra G. Hames, PhD

Latest:

Racial/Ethnic Disparities in Cost-Related Barriers to Care Among Near-Poor Beneficiaries in Medicare Advantage vs Traditional Medicare

Among near-poor Black and Hispanic individuals, Medicare Advantage was associated with increased vision care and some, although not uniform, reductions in access disparities vs traditional Medicare.


Daeho Kim, PhD

Latest:

Comparison of Mortality Between Medicare Advantage and Traditional Medicare Beneficiaries With Kidney Failure

The risk-adjusted 1-year mortality rate was not different between Medicare Advantage and traditional Medicare beneficiaries with kidney failure who initiated dialysis.


Brian P. O’Rourke, MA

Latest:

Integrating Primary Care and Public Health for Advance Care Planning

This article proposes a new model, Public-Primary ACP, that leverages coordination between primary care and public health workforces to improve delivery of advance care planning.



Esther Yi, PharmD

Latest:

Perspectives on Nonmedical Switching and the COVID-19 Pandemic: A Narrative Review

This review describes the impact of nonmedical switching of biologic therapies on US patients and providers, with a focus on switching to in-class alternatives.


Renaldo C. Blocker, PhD

Latest:

Understanding the Complexities of Equity Within the Emergence and Utilization of AI in Academic Medical Centers

This editorial discusses positions for academic medical centers to consider when designing and implementing artificial intelligence (AI) tools.


Qiang Yang, PhD

Latest:

Dosage and Outcomes in a Complex Care Intervention

Associations between intervention dosage and hospital use outcomes were observed among patients enrolled in a care management program serving individuals with complex needs.


Fayolah Richards, PharmD

Latest:

Insurer Costs of COVID-19 by Disease Severity and Duration

Payer costs for COVID-19 ranged from a mean of $505 for asymptomatic cases to $126,094 for severe cases with post–COVID-19 condition.


Xiang Huang, MD, PhD

Latest:

How Do Primary Community Hospitals Enact Early Response to COVID-19? The Experience From Chengdu, China

Our hospital is a primary hospital in Chengdu, China. Since February 5, our hospital has been listed as the primary designated medical unit for treating new patients with coronavirus disease 2019 (COVID-19) in Jinniu District. In this letter, we share our COVID-19 experience with readers.


Cori Rattelman, MS

Latest:

Health Systems and Telemedicine Adoption for Diabetes and Hypertension Care

Small practices reduced their use of telemedicine during early stages of the COVID-19 pandemic. Technical support may help expand and maintain telemedicine in small practices.


Richard J. McCarthy, MD

Latest:

Patient Experience After Modifying Visit Delivery During the COVID-19 Pandemic

Coronavirus disease 2019 (COVID-19) was associated with immediate weekly visit trend decreases for overall, primary care, and specialty care with long-term recovery trends; transformation to virtual visits; and increasing long-term trends for meeting patient scheduling and visit needs.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.